131 related articles for article (PubMed ID: 3497611)
1. Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor.
Pixley RA; Schmaier A; Colman RW
Arch Biochem Biophys; 1987 Aug; 256(2):490-8. PubMed ID: 3497611
[TBL] [Abstract][Full Text] [Related]
2. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III.
Pixley RA; Schapira M; Colman RW
Blood; 1985 Jul; 66(1):198-203. PubMed ID: 3873967
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional characterization of factor XII.
Tans G; Rosing J
Semin Thromb Hemost; 1987 Jan; 13(1):1-14. PubMed ID: 3551074
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.
de Agostini A; Lijnen HR; Pixley RA; Colman RW; Schapira M
J Clin Invest; 1984 Jun; 73(6):1542-9. PubMed ID: 6725552
[TBL] [Abstract][Full Text] [Related]
5. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
6. The regulation of human factor XIIa by plasma proteinase inhibitors.
Pixley RA; Schapira M; Colman RW
J Biol Chem; 1985 Feb; 260(3):1723-9. PubMed ID: 2578463
[TBL] [Abstract][Full Text] [Related]
7. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
[TBL] [Abstract][Full Text] [Related]
8. Activation of factor XII and prekallikrein with polysaccharide sulfates and sulfatides: comparison with kaolin-mediated activation.
Shimada T; Sugo T; Kato H; Yoshida K; Iwanaga S
J Biochem; 1985 Feb; 97(2):429-39. PubMed ID: 2861197
[TBL] [Abstract][Full Text] [Related]
9. Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment.
Schapira M; Ramus MA; Jallat S; Carvallo D; Courtney M
J Clin Invest; 1986 Feb; 77(2):635-7. PubMed ID: 3484756
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
[TBL] [Abstract][Full Text] [Related]
11. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
12. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis.
Nuijens JH; Huijbregts CC; Eerenberg-Belmer AJ; Abbink JJ; Strack van Schijndel RJ; Felt-Bersma RJ; Thijs LG; Hack CE
Blood; 1988 Dec; 72(6):1841-8. PubMed ID: 3264190
[TBL] [Abstract][Full Text] [Related]
13. Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.
Kaplan AP; Joseph K
Clin Rev Allergy Immunol; 2016 Oct; 51(2):207-15. PubMed ID: 27273087
[TBL] [Abstract][Full Text] [Related]
14. Effect of heparin on the activation of factor XII and the contact system in plasma.
Pixley RA; Cassello A; De La Cadena RA; Kaufman N; Colman RW
Thromb Haemost; 1991 Nov; 66(5):540-7. PubMed ID: 1725067
[TBL] [Abstract][Full Text] [Related]
15. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
Tans G; Janssen-Claessen T; Rosing J; Griffin JH
Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
[TBL] [Abstract][Full Text] [Related]
16. The plasma bradykinin-forming pathways and its interrelationships with complement.
Kaplan AP; Ghebrehiwet B
Mol Immunol; 2010 Aug; 47(13):2161-9. PubMed ID: 20580091
[TBL] [Abstract][Full Text] [Related]
17. Complexes of Cl-inhibitor (Cl-INH) and hemostatic enzymes in normal plasma.
Donaldson VH; Harrison RR
Adv Exp Med Biol; 1983; 156():149-55. PubMed ID: 6602461
[No Abstract] [Full Text] [Related]
18. The effect of C1 inhibitor upon Hageman factor autoactivation.
Weiss R; Silverberg M; Kaplan AP
Blood; 1986 Jul; 68(1):239-43. PubMed ID: 3487356
[TBL] [Abstract][Full Text] [Related]
19. Zinc ions promote the binding of factor XII/factor XIIA to acidic phospholipids but have no effect on the binding of high-Mr kininogen.
Schousboe I; Halkier T
Eur J Biochem; 1991 Apr; 197(2):309-14. PubMed ID: 2026153
[TBL] [Abstract][Full Text] [Related]
20. Initiation of contact activation by sulfatides.
Tans G; Griffin JH
Adv Exp Med Biol; 1983; 156():63-72. PubMed ID: 6602464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
